PB2289: PRELIMINARY DATA FROM A FIRST-IN HUMAN PHASE II STUDY OF SEQUENTIAL USE OF SELINEXOR AND CD19 CHIMERIC ANTIGEN RECEPTOR MODIFIED T-CELL THERAPY (CART19) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

PB2289: PRELIMINARY DATA FROM A FIRST-IN HUMAN PHASE II STUDY OF SEQUENTIAL USE OF SELINEXOR AND CD19 CHIMERIC ANTIGEN RECEPTOR MODIFIED T-CELL THERAPY (CART19) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

Bibliographic Details
Main Authors: Ying Zhang, Xiangping Zong, Jiaqi LI, Sixun Jia, Hongzhi Geng, Liangyu Zeng, Qin Yang, Wenzhi Cai, Shuangzhu Liu, Yutong Lu, Lei Yu, Caixia LI, Depei Wu
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000975884.42135.d7

Internet

http://journals.lww.com/10.1097/01.HS9.0000975884.42135.d7

Similar Items